Document Detail


Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines.
MedLine Citation:
PMID:  19301310     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Reports indicate that vascular endothelial growth factor receptor type 3 (VEGFR3) regulates cellular functions such as invasion, proliferation, and chemo-resistance. However, the exact function of the VEGFR3 signaling axis in prostate epithelial cells is poorly characterized. METHODS: The goal of this study was to evaluate whether TGFbeta1 in combination with VEGFD can promote pre-malignant invasive activities of intermediate basal cells (IBC-10a) isolated from human prostate cancer (Gleason score 6). RESULTS: hTERT immortalized IBC-10a cells normally grew as confluent "cobblestoned" monolayers, but treatment with TGFbeta1 (10 ng/ml for 2-6 hr) dissociated the cell-cell junctions and induced VEGFR3 translocation to the cell surface. This event was not inhibited by 10 microM cycloheximide or puromycin, indicating transcription and protein synthesis were not required. We further discovered that TGFbeta1 in combination with VEGFD induced a significant increase in the invasive activity of IBC-10a cells (>26% and 53% after 24 and 48 hr, respectively) in modified Boyden Chamber assays. TGFbetaRII receptor antibodies specifically blocked TGFbeta1 induction of VEGFR3 translocation to the cell surface and blocked VEGFD-induced invasion. Zymograms revealed that TGFbeta1 (and not VEGFR3) stimulated the secretion of MMP-2 and MMP-9, presumably to promote cell invasion. The cell invasion assays confirmed that antibodies specific for TGFbetaII receptor, MMP-2 and MMP-9 and VEGFR3, independently blocked TGFbeta1-induced invasion. CONCLUSIONS: For the first time, we have demonstrated the mechanism by which TGFbeta1 stimulates VEGFD/VEGFR3 receptor axis activation leading to increased cell migration and invasion by primary intermediate basal cell cultures.
Authors:
S M Goodyear; S B Kheyfets; F U Garcia; M E Stearns
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  The Prostate     Volume:  69     ISSN:  1097-0045     ISO Abbreviation:  Prostate     Publication Date:  2009 Jun 
Date Detail:
Created Date:  2009-05-25     Completed Date:  2009-06-18     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  8101368     Medline TA:  Prostate     Country:  United States    
Other Details:
Languages:  eng     Pagination:  982-90     Citation Subset:  IM    
Affiliation:
Molecular Pathobiology Program, Drexel University College of Medicine, Philadelphia, Pennsylvania 19102-1192, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Line, Transformed
Chemotaxis / drug effects,  physiology
Humans
Intercellular Junctions / metabolism
Male
Matrix Metalloproteinase 2 / metabolism
Matrix Metalloproteinase 9 / metabolism
Prostate / metabolism,  pathology
Prostatic Neoplasms / metabolism*,  pathology*
Signal Transduction / drug effects,  physiology
Transforming Growth Factor beta1 / metabolism*,  pharmacology
Tumor Cells, Cultured
Vascular Endothelial Growth Factor D / metabolism*,  pharmacology
Vascular Endothelial Growth Factor Receptor-3 / metabolism*
Grant Support
ID/Acronym/Agency:
CA07739/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Transforming Growth Factor beta1; 0/Vascular Endothelial Growth Factor D; EC 2.7.10.1/Vascular Endothelial Growth Factor Receptor-3; EC 3.4.24.24/Matrix Metalloproteinase 2; EC 3.4.24.35/Matrix Metalloproteinase 9

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Regulation of cell survival by resveratrol involves inhibition of NF kappa B-regulated gene expressi...
Next Document:  A novel image-guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging n...